An­oth­er biotech is feel­ing the heat as it un­der­goes 're­or­ga­ni­za­tion' with plans to lay off about 100

Adap­tive Biotech­nolo­gies is join­ing the horde of biotechs that have been forced to lay off staff in the wake of grow­ing mar­ket chal­lenges.

The Seat­tle biotech an­nounced Wednes­day it will trim its work­force by about 12%, which would equal about 100 em­ploy­ees. In ad­di­tion, it’s con­duct­ing a wide­spread re­or­ga­ni­za­tion of the com­pa­ny that will see it “de­pri­or­i­tize” any and all pro­grams not re­lat­ed to its new fo­cus of “min­i­mal resid­ual dis­ease” and im­mune med­i­cine.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER